AU Stock MarketDetailed Quotes
NXS Next Science Ltd
- 0.260
- -0.030-10.34%
20min DelayNot Open May 22 16:00 AET
75.84MMarket Cap-2549P/E (Static)
0.295High0.250Low281.88KVolume0.285Open0.290Pre Close75.77KTurnover0.66552wk High0.19%Turnover Ratio291.70MShares0.18052wk Low-0.102EPS TTM38.82MFloat Cap4.730Historical HighLossP/E (Static)149.30MShs Float0.180Historical Low-0.102EPS LYR15.52%Amplitude--Dividend TTM3.94P/B1Lot Size--Div YieldTTM
About Next Science Ltd Company
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.
Company Profile
SymbolNXS
Company NameNext Science Ltd
Founded2017
MarketASX
Fiscal Year Ends12-31
Address264-278 George Street Level 14, Australia Square
CitySydney
CountryAustralia
Zip Code2000
Phone+61 291887772
Websitehttps://www.nextscience.com
Company Executives
- Name
- Position
- Salary
- Judith Mitchell
- Chief Executive Officer,Managing Director
- --
- Mark Raymond Compton
- Non-Executive Director,Non-Executive Chairman
- --
- Daniel (Dan) Spira
- Non-Executive Director
- --
- Bruce Alan Hancox
- Non-Executive Director
- --
- Aileen Stockburger
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg